Kalbe Farma Tbk.

KLBF · Kesehatan · Farmasi & Riset Kesehatan

675

-38.64% 1-year change

Last completed session, Oct 16, 2026

Daily closes over the past year, to Oct 16, 2026

What makes up the 58

  • Value

    55Against 788 other IDX companies

    Priced about in line with comparable stocks.

    P/E
    8.8×
    72%Cheaper than 72% of other IDX companies
    P/B
    1.3×
    45%Cheaper than 45% of other IDX companies
    Dividend yield
    3%
    47%Higher than 47% of other IDX companies
  • Quality

    78Against 788 other IDX companies

    More profitable than most comparable stocks.

    Return on equity
    14.8%
    80%Higher than 80% of other IDX companies
    Return on assets
    11.2%
    87%Higher than 87% of other IDX companies
    Net margin
    9.8%
    67%Higher than 67% of other IDX companies
  • Growth

    50Against 788 other IDX companies

    Growing roughly in line with comparable stocks.

    Profit, last 4 quarters
    +5.8%
    49%Higher than 49% of other IDX companies
    Profit, 3-year yearly
    +2.7%
    47%Higher than 47% of other IDX companies
    Profit, latest quarter vs a year ago
    -0.8%
    45%Higher than 45% of other IDX companies
    Revenue, latest quarter vs a year ago
    +18.2%
    58%Higher than 58% of other IDX companies
  • Momentum

    21Against 836 traded stocks

    Has lagged most stocks over the past year.

    1-year price change
    -43.3%
    21%Better than 21% of traded stocks
  • Liquidity

    93Against 836 traded stocks

    Among the most traded stocks on IDX.

    Value traded per day, 30 days
    IDR 39B
    93%Higher than 93% of traded stocks
  • Retail penalty

    −1Retail brokers XL, XC, RO, YP, past 20 sessions

    Retail is underwater here, deeper than 13% of the other stocks where it is, so 1 point comes off the rating.

    Retail average buy
    718
    Close vs that average
    -6%
    Retail net bought
    -294K lots

Similar stocks

Rated most like KLBF across the five pillars. Change is over the past year.